Transvaginal mesh implants for prolapse and incontinence eroded through tissue in thousands of women — causing chronic pain, infection, and repeat surgeries. The litigation is among the largest in history.
Transvaginal mesh was implanted in hundreds of thousands of women to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Manufacturers including Ethicon (J&J), Boston Scientific, C.R. Bard, and American Medical Systems marketed mesh as a durable repair.
The mesh proved prone to erosion — cutting through vaginal tissue and into surrounding organs — causing chronic pain, painful intercourse, infection, and repeat surgeries. Some women underwent multiple revision operations without full removal being possible.
Litigation produced some of the largest MDLs in history — billions in settlements and verdicts across multiple manufacturers. While the major MDLs have largely resolved, remaining and newly diagnosed claims continue to be evaluated.
TVM litigation produced billions in settlements across multiple manufacturers, and the major MDLs have largely resolved. Remaining claims — including late-diagnosed complications — continue to be evaluated under state-specific deadlines.
Qualification criteria change as litigation develops. The only way to know whether your experience may fit the current criteria is a review.
The Transvaginal Mesh (TVM) campaign is pre-selected below. Tell us what happened — a specialist will review whether your information may fit the current criteria.
You are reviewing: Transvaginal Mesh (TVM) Claims. Complete the form — a case specialist may follow up if your information appears to fit.
Attorney advertising. The Torts Attorney provides legal marketing and case-acquisition services and is not a law firm. Submitting this form does not create an attorney-client relationship and does not guarantee review, acceptance, or any outcome. Prior results do not guarantee similar outcomes.